Colorimetric MTT Assessment of Antifungal Activity of ZnO Nanowires Against Candida Dubliensis Bioflm

Document Type : Original Article


1 Department of Medical Mycology, Tarbiat Modares University of Medical Sciences, Tehran, Iran.

2 Department of Biochemistry, Biochemistry and Metaolic Disorder Research Center, Gorgan University of Medical Sciences, Gorgan, Iran.

3 School of Engineering, Tarbiat Modares University of Medical Sciences, Tehran, Iran.


Background and Objective: In recent years the incidence opportunistic fungual infections has in creased dramatically.One of the most common fungal pathogen Candida dubliniensis, colonization and biofilm formation on the surfaces of medical devices. The aim of this study was to evaluate the inhibitory activity of zinc oxide nanoparticles against C. dubliniensis biofilm formation by the MTT colorimetric method is measured.
Materials and Methods: In this study, ZnO nanoparicles using the sol-gel was prepared, size and type of particles, respectively, by scanning electron microscopy (SEM) and X-Ray-Diffraction were determined. The Minimum inhibitory concentration (MIC) of growth dilution method was done by microdilution test.
C.dubliensis biofilms (DSY 1024) after 48h incubation at 37ºC inhibited the information of nanoparticles ZnO,SDS and Fluconazole drug as a positive control on Candida biofilms was assessed by MTT tetrasolium salt reduction. The collected data using statistical t-test and SPSS software were analyzed.
Results: The results of this study showed that a minimum concentration of inhibitor nanoparticles, ZnO, SDS and fluconazole, respectively: 9/25, 0/02, 8 µg/ml. Inhibitory strength of biofilm adhesion in the presence of nanoparticles ZnO, SDS and fluconazole, equivalent to more than twice the concentration of the MIC was determined.
Conclusion: In this study, ZnO nanoparticles synthesized by a chemical method indicat that has anti-fungal properties. Therefore, a new way of working for the prevention of biofilm formation of Candida biofilms particularly associated with medical devices to be.


1-Zaini F, Mehbod ASA, Emami M. Comprehensive Medical Mycology. Tehran: University of Tehran Press; 2009. P. 353-57.
2- Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbial Rev 2004;17(2):255-67.
3- D'Antonio D, Romano F, Pontieri E, Fioritoni G, Caracciolo C, Bianchini S, et al. Catheter–related candidemia caused by candida lipolytica in a patient receiving allogeneic bone marrow transplantation. J clin Microbial 2002;40(4):1381-6.
4- Singh PK, Parsek MR, Greenberg EP, Welsh MJ. A component of innate immunity prevents bacterial biofilm development.  Nature 2002;417(6888):552-5.
5-Wigglesworth–cooksey B, Berglud D, Cooksey KE. Cell-cell and cell-surface interactions in an illuminated biofilm: Implications for marine sediment stabilization. Geochem Trans 2001;2(1):75-82.
6-Douglas LJ.Candida biofilms and their role in infection. Trends Microbial 2003;11(1):30-6.
7- Eick S, Seltmann T, Pfister W. Efficacy of antibiotics to strains of periodontopathogenic bacteria within a single species biofilm - an in vitro study. J clin periodontal 2004;31(5):376-83.
8- Jain N, Kohli R, Cook E, Gialanella P, Chang T, Fries BC. Biofilm formation by and antifungal susceptibility in Candida isolates from urine. Apple Environ Microbiol 2007; 73(6):1697-703.
9- Khan, Aurangzeb. Synthesis, characterization and luminescence properties zinc oxide nanostructures [dissertation]. Ohaio:the college of Arts and siences;  2006.
10-Messager S, Goddard PA, Dettmar PW, Maillard JY. Comparison of two in vivo and two ex vivo tests to assess the antibacterial activity of several antiseptics. J Hosp Infect 2004;58(2):115–12.
11-Dettenkofer M, Wenzler S, Amthor S, Antes G, Motschzall E, Daschner FD. Does disinfection of environmental surfaces influence nosocomial infection rates? A systematic review. Am J Infect Control 2004;32(2):84-9.
12-Wang LI. Photoluminescence Study of Asgrown and Thermally Annealed Bulk ZnO Crystals [dissertation]. Morgantown: West Virginia Universi; 2004.
13-Nebauer E,  Merkel  U, Würfl  J. Structure and stability studies on W, WSi, WSiN/GaAs systems by XRD.  Semicond Sci Technol 1997;12(9):1072–1078.
14-Atmaca S, GÜL K, ÇIÇEK R. The effect of zinc on Microbial growth medical .J of Medical Sciences 1998;28:595-597.
15- LaFleur MD, Kumamoto CA, Lewis K. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother 2006;50(11):3839–46.
16- Akiba N, Hayakava I, Keh ES, Watanabe A. Antifungal effect of a tissue conditionar coatingagent
with TiO2 photocatalyst. J Med Dent Sci 2005; 52: 223_7.
17-Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007;20(1):133–63.
18- Kojic EM, Darouiche RO. Candida infections of medical devices. Clinical Microbiology Reviews
2004; 14: 255–67.
19-Blankenship JR, Mitchell AP. How to build a biofilm: a fungal perspective. Curr Opin Microbiol 2006;9(6):588–94.
20-Lia JH, Hong RY, Lic MY, lib HZ , Zhenged Y, Dine J. Effects of ZnO nanoparticles on the mechanical and antibacterial properties of poly are than coating. Progress in organic coating 2009;64(4):504-9.
21-Nett JE, Guite KM, Ringeisen A, Holoyda KA, Andes DR. Reduced Biocide Susceptibility in Candida albicans Biofilms. Antimicrob Agents chemother Sept 2008;52(9):3411–3.
22- Panácek A, Kolár M, Vecerová R, Prucek R, Soukupová J, Krystof V, et al. Antifungal activity of silver nanoparticles against Candida spp. Biomaterials  2009;30(31): 6333–40.
23-Saiwa A, Hang I and Ding J.Effects of ZnO nanoparticles on the mechanical and antibacterial properties of polyurethane coating.J Elsevier.2009; 64:504-509.
24-Kumamoto CA. Candida biofilms. Curr Opin Microbiol 2002;5(6):608–11.
25-Yamamoto O, IidaY. Antifungal characteristics of spherical carbon materials with Zinc Oxide. J Ceram Soc JPN 2003;111(1296):614-6.
26-Zhang L, Ding Y, Povey M, York D. ZnO nanofluids – A potential antibacterial agent. Prog Nat Sci 2008;18(8):939–44.
27-Ramage G, Vande Walle K, Wickes BL, López-Ribot JL. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents  Chemother 2001;45(9):2475–9.
28-Seneviratne CJ, Silva  WJ,  Jin LJ, Samaranayake YH, Samaranayake LP. Architectural analysis, viability assessment and growth kinetics of Candida albicans and Candida glabrata biofilms. Arch Oral Biol 2009;5 4(11):1052 -60.
29-Plumb JA. cell sensivity assays: the MTT assay. Methods Mol Med 2004;88:165-9.
30-Gordon O, Vig Slenters TV, Brunetto PS, Villaruz AE, Sturdevant  DE, Otto M, et al. Silver coordination polymers for prevention of implant infection; thiol interaction, impact on respiratory chain enzymes, and hydroxyl radical induction. Antimicrob Agents Chemother 2010;54(10):4208-18.